Baxter International Mergers and Acquisitions Summary

Medical Products Company

Baxter International has acquired 20 companies, including 5 in the last 5 years. A total of 5 acquisitions came from private equity firms. It has also divested 5 assets.

Baxter International’s largest acquisition to date was in 2013, when it acquired Gambro AB for $3.9B. It’s largest disclosed sale occurred in 2014, when it sold Baxter International - Marketed Vaccines to Pfizer for $635M. Baxter International has acquired in 8 different US states, and 7 countries. The Company’s most targeted sectors include medical products (62%) and healthcare services (17%).

Join Mergr and gain access to Baxter International’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the medical products sector.

M&A Summary

  • M&A Total Activity23
    • M&A Buy Activity18
    • M&A Sell Activity5
  • Total Sectors Invested 4
  • Total Countries Invested 7
  • M&A Buy/Sell Connections 12
  • M&A Advisors 1

Baxter International, Inc.

One Baxter Parkway,
Deerfield, Illinois 60015
United States,
(224) 948-2000
www.baxter.com

Baxter International Inc. develops, manufactures and markets drugs and medical products for people with a variety of medical conditions. Baxter's operations are comprised of the BioScience and Medical Products segments. The BioScience business processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; biosurgery products; and select vaccines. The Medical Products business manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, and inhalation anesthetics. The business also provides products and services related to pharmacy compounding, drug formulation and packaging technologies. In addition, the Medical Products business provides products and services to treat end-stage renal disease, or irreversible kidney failure. Baxter International was founded in 1931 and is based in Deerfield, Illinois.


M&A Summary

Buy vs Sell

Year ≤ '15 '16 '17 '18 '19 '20 T
Buy (0.8/yr) # 14 1 - 1 2 - 18
vol $6.8B $625M $580M $8.0B
Sell (0.0/yr) # 5 - - - - - 5
vol $657M $657M
  23

Most Recent M&A

Company Date Value Type
sanofi-aventis U.S. LLC (Seprafilm Adhesion Barrier) 2019-12-02 350M USD Divestiture
, United States · www.seprafilm.us
Cheetah Medical, Inc. 2019-09-10 230M USD Add-on Acquisition
Newton Center, Massachusetts · www.cheetah-medical.com
Mallinckrodt plc - Recothrom and Preveleak 2018-03-19 - Divestiture
Dublin, Ireland
Claris Injectables Ltd. 2016-12-15 625M USD Divestiture
Ahmedabad, India · www.clarisinj.com
Baxalta, Inc. 2015-06-05 - Spin Off
Deerfield, Illinois · www.baxalta.com
SuppreMol GmbH 2015-03-04 225M EUR Add-on Acquisition
Planegg, Germany · www.suppremol.com
Baxter International Inc. - Marketed Vaccines 2014-07-30 635M USD Divestiture
Orth, Austria
Chatham Therapeutics LLC 2014-04-02 70M USD Add-on Acquisition
, United States
Flowsense Medical Ltd. 2013-09-10 10M USD Add-on Acquisition
Misgav, Israel
Gambro AB 2013-09-06 3.9B USD Add-on Acquisition
Stockholm, Sweden · www.gambro.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Medical Products 11 (61%) 6.1B (77%) 1 (20%) 22M (3%)
Life Science 3 (17%) 794M (10%) 3 (60%) 635M (97%)
Healthcare Services 3 (17%) 1.0B (13%) 1 (20%) -
Distribution 1 (6%) - - -
Total 18 $8.0B 5 $657M

By Geo

State/Country Buy Value Sell Value
United States 12 2.5B 3 -
  California 3 346M - -
  Illinois - - 2 -
  Pennsylvania 1 338M - -
  New York 1 259M - -
  Minnesota 1 325M - -
  Massachusetts 1 230M - -
  Indiana 1 219M - -
  Colorado 1 380M - -
Austria 1 715M 1 635M
Germany 1 225M - -
India 1 625M - -
Ireland 1 - - -
Israel 1 10M - -
Japan - - 1 22M
Sweden 1 3.9B - -
Domestic 12 (67%) 2.5B (31%) 3 (60%) -
Cross-border 6 (33%) 5.5B (69%) 2 (40%) 657M (100%)
Total 18 $8.0B 5 $657M

Top M&A Advisors

Financial Deals
Credit Suisse Investment Banking
1

Deal Values

buy # Total
> $1B 1 $3.9B
$100M to $1B 12 $4.0B
< $100M 2 $80M
TOTAL $8.0B
Largest Gambro AB
$3.9B (2013-09-06)
sell # Total
$100M to $1B 1 $635M
< $100M 1 $22M
TOTAL $657M
Largest Baxter International Inc. - Marketed Vaccines
$635M (2014-07-30)

M&A Connections

Deals %
Acquired from
PE Firm(s)
50%
5 50%
Strategic(s)
50%
5 50%
Divested to
Strategic(s)
100%
4 100%

 Subscribe to unlock this and 148,010
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.8K Private Equity Firms
  • 135K M&A Transactions
  • 144K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.0K M&A Advisors
    (Investment Banks and Law Firms)
  • 37K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.